AAAAAA
Results: 1-25/390
Authors:
PAASSILTA M
KERVINEN K
PEUHKURINEN KJ
KESANIEMI YA
Citation: M. Paassilta et al., THROMBOLYSIS WITH TISSUE-PLASMINOGEN ACTIVATOR ENHANCES SERUM LIPOPROTEIN(A) LEVELS COMPARED TO STREPTOKINASE AND CONSERVATIVE TREATMENT INPATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Fibrinolysis, 10(5-6), 1996, pp. 263-268
Authors:
HILDEBRAND M
BHARGAVA AS
BRINGMANN P
SCHUTT A
VERHALLEN P
Citation: M. Hildebrand et al., PHARMACOKINETICS OF THE NOVEL PLASMINOGEN-ACTIVATOR DESMODUS-ROTUNDUSPLASMINOGEN-ACTIVATOR IN ANIMALS AND EXTRAPOLATION TO MAN, Fibrinolysis, 10(5-6), 1996, pp. 269-276
Authors:
BILLSTROM A
KINNBY B
LECANDER I
ASTEDT B
Citation: A. Billstrom et al., PRODUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN HUMAN PERIPHERAL-BLOOD MONOCYTES UP-REGULATED IN-VITRO BY THE QUINOLINE-3-CARBOXAMIDE, LINOMIDE, Fibrinolysis, 10(5-6), 1996, pp. 277-283
Authors:
ALLAN EH
MARTIN TJ
Citation: Eh. Allan et Tj. Martin, RECEPTOR-MEDIATED EFFECT OF THROMBIN ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 SYNTHESIS IN RAT OSTEOBLAST-LIKE CELLS, Fibrinolysis, 10(5-6), 1996, pp. 285-293
Authors:
NORDENGREN J
CASSLEN B
LECANDER I
Citation: J. Nordengren et al., PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS, Fibrinolysis, 10(5-6), 1996, pp. 295-302
Authors:
YOSHIDA E
OHMURA S
KAWANO J
SUGIKI M
KWAAN HC
MARUYAMA M
Citation: E. Yoshida et al., REGULATION OF THE SECRETION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN T98G HUMAN GLIOBLASTOMA CELLS BY CYTOKINES AND DEXAMETHASONE, Fibrinolysis, 10(5-6), 1996, pp. 303-307
Authors:
MAIER JAM
MARIOTTI M
MENEGHINI L
CAVALLARO U
WU Z
MASSAZZA G
CAMPIONI D
CORALLINI A
BARBANTIBRODANO G
SORIA MR
Citation: Jam. Maier et al., FIBROBLAST GROWTH-FACTOR-2 AND THE PROTEASE ACTIVITY OF TUMOR-CELLS ISOLATED FROM BK VIRUS TAT TRANSGENIC MICE/, Fibrinolysis, 10(5-6), 1996, pp. 309-315
Authors:
PRINS J
LEUS FR
BOUMA BN
VANRIJN HJM
Citation: J. Prins et al., DIFFERENTIATION OF THE ROLES OF THE APOLIPOPROTEIN(A) AND LDL MOIETY IN THE BINDING OF LIPOPROTEIN(A) TO LIMITED PLASMIN DIGESTED DES AA FIBRIN, Fibrinolysis, 10(5-6), 1996, pp. 317-324
Authors:
PARAMO JA
ACIENFUEGOS J
MONTES R
HERMIDA J
PARDO F
PANIZO C
ROCHA E
Citation: Ja. Paramo et al., CONTRIBUTION OF CYTOKINES TO HYPERFIBRINOLYSIS DURING ORTHOTOPIC LIVER-TRANSPLANTATION AND EFFECT OF APROTININ, Fibrinolysis, 10(5-6), 1996, pp. 325-329
Authors:
MYRUP B
ROSSING P
JENSEN T
GRAM J
KLUFT C
JESPERSEN J
Citation: B. Myrup et al., FIBRINOLYSIS IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH AND WITHOUT NEPHROPATHY, Fibrinolysis, 10(5-6), 1996, pp. 331-335
Authors:
CARMELIET P
COLLEN D
Citation: P. Carmeliet et D. Collen, TARGETED GENE MANIPULATION AND TRANSFER OF THE PLASMINOGEN AND COAGULATION SYSTEMS IN MICE, Fibrinolysis, 10(4), 1996, pp. 195-213
Authors:
BESSER D
VERDE P
NAGAMINE Y
BLASI F
Citation: D. Besser et al., SIGNAL-TRANSDUCTION AND THE U-PA U-PAR SYSTEM, Fibrinolysis, 10(4), 1996, pp. 215-237
Authors:
PIETRUCHA T
GOLANSKI J
BAJ Z
TCHORZEWSKI H
GREGER J
WATALA C
Citation: T. Pietrucha et al., FLOW CYTOMETRIC ANALYSIS OF THE PREVENTION OF PLATELET ACTIVATION BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE, Fibrinolysis, 10(4), 1996, pp. 239-248
Authors:
SONG KS
LEE A
PARK QE
LEE SM
KWON OH
Citation: Ks. Song et al., THE RELATIONSHIP BETWEEN CYTOKINE CONCENTRATIONS AND HEMOSTATIC ABNORMALITIES IN PATIENTS WITH LIVER-CIRRHOSIS OF POSTVIRAL OR CRYPTOGENIC ORIGIN, Fibrinolysis, 10(4), 1996, pp. 249-254
Authors:
MIRSHAHI S
SORIA J
NELLES L
SORIA C
FAURE JP
POULIQUEN Y
MIRSHAHI M
Citation: S. Mirshahi et al., PLASMINOGEN ACTIVATORS IN HUMAN CORNEAL FIBROBLASTS - SECRETION, CELLULAR-LOCALIZATION, AND REGULATION, Fibrinolysis, 10(4), 1996, pp. 255-262
Authors:
LIJNEN HR
COLLEN D
Citation: Hr. Lijnen et D. Collen, STAPHYLOKINASE, A FIBRIN-SPECIFIC BACTERIAL PLASMINOGEN-ACTIVATOR, Fibrinolysis, 10(3), 1996, pp. 119-126
Authors:
JUHANVAGUE I
ALESSI MC
Citation: I. Juhanvague et Mc. Alessi, FIBRINOLYSIS AND RISK OF CORONARY-ARTERY DISEASE, Fibrinolysis, 10(3), 1996, pp. 127-136
Authors:
DEBONO D
Citation: D. Debono, CAN CORONARY THROMBOLYSIS MEET THE CHALLENGE OF PRIMARY ANGIOPLASTY, Fibrinolysis, 10(3), 1996, pp. 137-142
Authors:
TVEDSKOV TF
VAD H
ALBRECHTSEN OK
GRAM J
Citation: Tf. Tvedskov et al., TISSUE THROMBOPLASTIN INDUCES RAPID INHIBITION OF FIBRINOLYSIS IN RABBITS, Fibrinolysis, 10(3), 1996, pp. 143-149
Authors:
BERNAT A
HOFFMANN P
SAINTEMARIE M
HERBERT JM
Citation: A. Bernat et al., THE SYNTHETIC PENTASACCHARIDE SR-90107A ORG-31540 ENHANCES TISSUE-TYPE PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS IN RABBITS/, Fibrinolysis, 10(3), 1996, pp. 151-157
Authors:
WIERIK EJMVT
KLUFT C
VANDENBERG H
WESTSTRATE JA
Citation: Ejmvt. Wierik et al., CONSUMPTION OF REDUCED-FAT PRODUCTS, HEMOSTATIC PARAMETERS AND ORAL GLUCOSE-TOLERANCE TEST, Fibrinolysis, 10(3), 1996, pp. 159-166
Authors:
CHENG XF
POHL G
BACK O
WALLEN P
Citation: Xf. Cheng et al., CHARACTERIZATION OF RECEPTORS INTERACTING SPECIFICALLY WITH THE B-CHAIN OF TISSUE-PLASMINOGEN ACTIVATOR ON ENDOTHELIAL-CELLS, Fibrinolysis, 10(3), 1996, pp. 167-175
Authors:
LIJNEN HR
SILENCE K
HARTMANN M
GUHRS KH
GASE A
SCHLOTT B
COLLEN D
Citation: Hr. Lijnen et al., FIBRINOLYTIC PROPERTIES OF STAPHYLOKINASE MUTANTS OBTAINED BY CLUSTERED CHARGE-TO-ALANINE MUTAGENESIS, Fibrinolysis, 10(3), 1996, pp. 177-182
Authors:
SHI GY
HSU CC
CHANG BI
TSAI CF
HAN HS
LAI MD
LIN MT
CHANG WC
WING LYC
JEN CJ
TANG MJ
WU HL
Citation: Gy. Shi et al., REGULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN ENDOTHELIAL-CELLS BY TISSUE-TYPE PLASMINOGEN ACTIVATORS, Fibrinolysis, 10(3), 1996, pp. 183-191
Authors:
HANKEY CR
RUMLEY A
HA T
LOWE GDO
LEAN MEJ
Citation: Cr. Hankey et al., PLASMA COAGULATION, FIBRINOLYSIS AND (PRO)VITAMINS IN THOSE WITH ISCHEMIC-HEART-DISEASE, Fibrinolysis, 10(3), 1996, pp. 193-193